All relevant data are within the manuscript and its Supporting Information files. They can be found in S3_File.zip.

1. Introduction {#sec001}
===============

Infectious disease research often relies on data generated through passive or active surveillance activities, which can suffer from important limitations due to variation in methods and capacities for data collection \[[@pone.0235920.ref001], [@pone.0235920.ref002]\]. Typically, researchers aim to collect data at a high spatial resolution, that is, in the form of small surveillance units such as counties or municipalities rather than states or nations \[[@pone.0235920.ref003], [@pone.0235920.ref004]\], though this may not always be seen as beneficial \[[@pone.0235920.ref005]\]. Conducting surveillance at a high spatial resolution, however, is often unrealistic when considering large areas and constrained resources \[[@pone.0235920.ref006], [@pone.0235920.ref007]\].

Data collected from infectious disease surveillance activities are often used in research involving mathematical or statistical models. In such analyses, matters related to data quality are of concern. The choice of spatial resolution is often based on data availability or chosen arbitrarily, with little attention given to whether this decision may impact model results. Aggregating data into larger spatial units can aid in computational efficiency, but creates the risk of introducing ecological fallacy \[[@pone.0235920.ref008]\] and masking heterogeneity within those larger units if conclusions are drawn inappropriately \[[@pone.0235920.ref009]--[@pone.0235920.ref011]\]. This would be particularly problematic when aiming to seek disease etiologies. This concept is related to the modifiable areal unit problem \[[@pone.0235920.ref012], [@pone.0235920.ref013]\] in its discussion of choices of spatial units impacting results. The modifiable areal unit problem is always present when using spatial data, but is infrequently acknowledged and rarely quantified \[[@pone.0235920.ref013]\]. The choice of spatial resolution may impact any models used; previous studies using mathematical or statistical models have investigated the importance of high resolution data by repeating analyses using data at different resolutions and then comparing results \[[@pone.0235920.ref010], [@pone.0235920.ref011], [@pone.0235920.ref014]\].

An additional challenge to high quality surveillance is the need for surveillance over a large spatial scale, referring to the entire area where surveillance is being conducted. Here, spatial scale differs from spatial resolution in their definitions as follows: spatial scale refers to the total spatial area being examined, while spatial resolution refers to the size of the individual spatial units within that area. Large-scale surveillance can be particularly challenging for nations with large land areas and populations. In these circumstances, there is potential benefit in identifying a smaller area, such as a state or group of states, where surveillance can adequately estimate the national disease burden. The characteristic of having smaller areas representative of the whole for a large range of sizes is known as scale invariance or fractality \[[@pone.0235920.ref015]\]. Scale invariance is ubiquitous in many socio-ecological patterns such as finance \[[@pone.0235920.ref016]\], ecology \[[@pone.0235920.ref017]\], biochemical processes \[[@pone.0235920.ref018]\], and biology across time scales \[[@pone.0235920.ref019]\].

Scale invariance is an infrequently examined concept in infectious disease surveillance and epidemiology in general, though it has relevance to many forms of data analysis or modeling. In research involving statistical or mathematical models, the scale used, whether an entire nation, portion of a nation, or other extent, may impact the structure and products of the model. Scale invariance in infectious disease research is more frequently used to describe scale-free networks, typically applied to human communicable diseases \[[@pone.0235920.ref020]\] or transmission paths of infectious diseases \[[@pone.0235920.ref021]\]. For practical purposes in epidemiology, identifying smaller regions that represent a larger area or even an entire nation could allow the design of targeted surveillance strategies and conserve resources \[[@pone.0235920.ref022]\]. Even in the absence of true scale invariance, self-similarity can be observed \[[@pone.0235920.ref015]\] where some smaller areas can be used to describe the whole. In other situations, however, the spatial scale of interest impacted the physical processes being studied \[[@pone.0235920.ref023]\].

The topics of spatial resolution and scale are relevant for research pertaining to numerous health outcomes. Here, Visceral Leishmaniasis is examined as a case study. Visceral Leishmaniasis (VL), caused by a *Leishmania infantum* parasite (known in Latin America as *Leishmania chagasi*) \[[@pone.0235920.ref024]\], is the most severe form of Leishmaniasis and is fatal in the vast majority of untreated cases \[[@pone.0235920.ref025]\]. The parasite is typically transmitted from an infected to a non-infected host through the bites of phlebotomine sand flies \[[@pone.0235920.ref026]\]. Visceral Leishmaniasis presentation can include symptoms such as fever, enlargement of the spleen and liver, and anaemia \[[@pone.0235920.ref025]\]. It is estimated that between 200,000 and 400,000 cases of VL occur worldwide annually, with approximately ten percent being fatal \[[@pone.0235920.ref027]\].

Brazil is one of ten world nations with the greatest VL burdens \[[@pone.0235920.ref025]\], with the remaining nations located primarily in East Africa and South and Southeast Asia \[[@pone.0235920.ref025]\]. Estimates report that 90% of VL cases that occur in the Americas occur in Brazil \[[@pone.0235920.ref025]\] where, canines are a disease reservoir \[[@pone.0235920.ref028]--[@pone.0235920.ref030]\]. The estimated age adjusted incidence rate from VL in Brazil is 1.84 cases per 100,000 population, and the mortality rate from VL in Brazil is 0.15 deaths per 100,000 population, with approximately eight percent of cases being fatal \[[@pone.0235920.ref031]\]. Areas of Brazil that previously had accounted for only 15% of all cases reported nationally now can see nearly half of the nation's cases \[[@pone.0235920.ref030]\]. The disease has also become more common in urban areas in recent decades \[[@pone.0235920.ref028], [@pone.0235920.ref032], [@pone.0235920.ref033]\], making it a major public health concern and an important target for surveillance programs. As of 2015, based on the data used for this study, the Federal District and 18 of the 26 states in Brazil meet the criterion of being an endemic state for VL, which is seeing at least one case in all three previous years \[[@pone.0235920.ref034]\]. The states that were not endemic at the time are Acre, Amapá, Amazonas, Espírito Santo, Paraná, Rondônia, Roraima, and Santa Catarina \[[@pone.0235920.ref034], [@pone.0235920.ref035]\]. As of 2019, Espírito Santo and Paraná became endemic states \[[@pone.0235920.ref035]\].

This study aims to assess the potential impact of using different spatial resolutions and scales on statistical and mathematical models using surveillance data applied to VL cases in Brazil. In order to do so, two objectives are pursued: (1) to determine if surveillance using incidence by state or municipality leads to different distributional fits of disease incidence; and (2) to determine if conducting VL surveillance on a region within Brazil would equivalently characterize the nation's VL incidence. This is done by using best fitting probability distributions to describe disease data without incorporating outside information. A conceptual visualization of the study aims is presented in [Fig 1](#pone.0235920.g001){ref-type="fig"}. Prior to conducting statistical analyses or models, researchers may need to decide whether to consider data using different spatial resolutions as well as the scale of analysis; the results of this study will provide insight into whether the subsequent results may be sensitive to this decision.

![Graphical overview of the study objectives: (a) fit distribution to annual incidence of Visceral Leishmaniasis (VL) by state, (b) fit distribution to annual incidence of VL by municipality, (c) fit distributions to annual incidence of VL by municipality within each state.\
Comparisons of these fitted distributions indicate whether characterizing VL incidence by state or municipality are equivalent, impacting statistical analyses using these data.](pone.0235920.g001){#pone.0235920.g001}

2. Methods and materials {#sec002}
========================

2.1 Study setting and data {#sec003}
--------------------------

The setting for this study is Brazil, the largest nation in South America in both land area and population. Case data were provided by the Brazilian Ministries of Health \[[@pone.0235920.ref036]\] and include VL case counts by municipality nationwide, with the exception of the Federal District, totaling 26 states and 5,561 municipalities. The Federal District was excluded because it is not a state with multiple municipalities, and therefore cannot be aggregated to differentiate between the municipality resolution and the state resolution. Yearly case counts by municipality between 2004 and 2014 are reported. Annual populations for each municipality are publicly available through the Brazilian Institute of Geography and Statistics \[[@pone.0235920.ref037]\] to calculate annual incidence, discretized to represent cases per 100,000 population per year. Population data were available for all years except 2007 and 2010. In these two years, the arithmetic means of the populations of the two adjacent years were used in place of the missing populations. Population data were available for 5,538 of the municipalities with VL data, providing the final sample for this study.

2.2 Inferring probability distributions {#sec004}
---------------------------------------

This study compares spatial resolutions and scales using probability distributions rather than by fitting models with assumptions and conducting a sensitivity analysis. This was done to avoid imposing assumptions of a particular model, keeping the examination of scale and resolution as the focus of analyses with regards to the characteristics of VL incidence itself rather than the relationship between incidence and other data. Best fitting distributions from multiple considered distributional families were fit for (1) annual incidence for each individual state using the municipality as the unit of surveillance; (2) annual incidence nationwide using the municipality as the unit of surveillance; and (3) annual incidence nationwide using the state as the unit of surveillance ([Fig 1](#pone.0235920.g001){ref-type="fig"}). All 11 years of observation were included.

Common candidate distributions were selected based on exploratory analyses, including visual analyses, quantiles, and summary statistics, and having a nonnegative support; wide ranges of parameters for each distribution were tested. The Poisson, Zero Inflated Poisson (ZIP), and Zero One Inflated Poisson (ZOIP) \[[@pone.0235920.ref038]\] distributions were selected as candidate distributions along with the Gamma, Exponential, Power Law, and Uniform distributions rounded to fit discrete data. These are described in [Table 1](#pone.0235920.t001){ref-type="table"}.

10.1371/journal.pone.0235920.t001

###### Candidate distributions used for fitting distributions.

![](pone.0235920.t001){#pone.0235920.t001g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Distribution                       Probability mass function
  ---------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Poisson                            $P\left( {X = x} \right) = \frac{\theta^{x}}{x!}{\text{exp}\left( {- \theta} \right)}$

  Zero Inflated Poisson (ZIP)        $P\left( {X = 0} \right) = \alpha + \left( {1 - \alpha} \right){\text{exp}\left( {- \theta} \right)}$\
                                     $P\left( {X = x} \right) = \left( {1 - \alpha} \right)\frac{\theta^{x}}{x!}{\text{exp}\left( {- \theta} \right)},\mspace{360mu} x > 1$

  Zero One Inflated Poisson (ZOIP)   $P\left( {X = 0} \right) = \alpha + \left( {1 - \alpha - \beta} \right){\text{exp}\left( {- \theta} \right)}$\
                                     $P\left( {X = 1} \right) = \beta + \left( {1 - \alpha - \beta} \right)\mspace{360mu}\theta{\text{exp}\left( {- \theta} \right)}$\
                                     $P\left( {X = x} \right) = \left( {1 - \alpha - \beta} \right)\mspace{360mu}\frac{\theta^{x}}{x!}{\text{exp}\left( {- \theta} \right)},\mspace{360mu} x > 1$

  Rounded Exponential                $P\left( {X = x} \right) = {\int_{0}^{x + 0.5}{f\left( y \right)\mspace{360mu} dy}} - {\int_{0}^{x - 0.5}{f\left( y \right)\mspace{360mu} dy}}$\
                                     $f\left( y \right) = \theta\mspace{360mu} exp\left( - \theta\mspace{360mu} y \right)$

  Rounded Gamma                      $P\left( {X = x} \right) = {\int_{0}^{x + 0.5}{f\left( y \right)\mspace{360mu} dy}} - {\int_{0}^{x - 0.5}{f\left( y \right)\mspace{360mu} dy}}$\
                                     $f\left( y \right) = \frac{\beta^{\alpha}}{\Gamma\left( \alpha \right)}\mspace{360mu} y^{\alpha - 1}\mspace{360mu} exp\left( {- \beta\mspace{360mu} y} \right)$

  Rounded Power Law                  $P\left( {X = x} \right) = {\int_{0}^{x + 0.5}{f\left( y \right)\mspace{360mu} dy}} - {\int_{0}^{x - 0.5}{f\left( y \right)\mspace{360mu} dy}}$\
                                     $f\left( y \right) = \frac{\alpha - 1}{x_{min}}\mspace{360mu}\left( \frac{x}{x_{min}} \right)^{- \alpha},\mspace{360mu} x > x_{min}$

  Rounded Uniform                    $P\left( {X = x} \right) = \frac{1}{b - a},\mspace{360mu} x \in \mspace{360mu}\mathbb{Z}\mspace{360mu} \cap \mspace{360mu}\left\lbrack a,\mspace{360mu} b \right\rbrack$
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Each distribution was evaluated for the optimal parameter set that minimizes the sum of absolute error (SAE), defined as $$SAE = \Sigma_{x}\left| {p\left( x \right) - p_{obs}\left( x \right)} \right|$$ where *p*(*x*) represents the probability of observing an incidence of *x* cases per 100,000 person-years based on the proposed distribution indicated in [Table 1](#pone.0235920.t001){ref-type="table"} and *p*~*obs*~(*x*) represents the observed proportion of incidence values equaling *x*. This measure compares similarities between the proposed distributions and observed data and is less sensitive to outliers than other measures \[[@pone.0235920.ref039]\].

The optimal parameter set for each distribution was found through simulated annealing \[[@pone.0235920.ref040]\], an optimization algorithm based on Monte Carlo sampling. The algorithm was run with three chains for 50,000 simulations to assure convergence. Convergence was reached if each of the three chains produced identical parameter values, indicating a lack of movement to other parameter values, for at least 500 iterations, as well as one of the following hierarchical criteria: (1) final parameter values across pairs of chains had an absolute difference of less than 0.01; (2) final parameter values had an absolute difference of less than 0.1 and associated SAE values had an absolute difference of less than 0.01; (3) SAE values had an absolute difference of less than 0.001. The second and third criteria were necessary due to some parameterizations having very similar SAE values. If convergence was not reached in 50,000 iterations, the three chains were restarted with the parameterization that led to the lowest SAE value in the chain as initial values, and the simulated annealing algorithm was repeated, increasing the simulation count by 5,000. This was repeated until convergence was reached.

2.3 Comparing distributions {#sec005}
---------------------------

### 2.3.1 Sensitivity to spatial resolution {#sec006}

The first aim of comparing distributions is to determine if changing the spatial resolution alters the distributional fit of incidence. In future modeling studies, differences in distributional fit could lead to changes in model outputs as a result of the spatial resolution of the data, whether aggregated by choice or through surveillance availability. This was done by comparing the fitted state-resolution distribution to an expected state-resolution distribution for the nation based on the fitted municipality-resolution distribution for the nation. This expected distribution was generated empirically by drawing Monte Carlo samples from the fitted municipality-resolution distribution.

If incidence is denoted by *X* as a random variable following the fitted municipality-resolution distribution for the nation; states are denoted by *s*; state *s* has *n*~*s*~ municipalities, denoted by *m*; and municipality *m* has a population of *p*~*my*~ in year *y*, this empirical distribution was generated by drawing 1,000 samples of $$z = \frac{\sum_{m = 1}^{s}p_{my}x_{m}}{\sum_{m = 1}^{s}p_{my}}$$ for each state under each year of observation. The numerator of [Eq (2)](#pone.0235920.e015){ref-type="disp-formula"} draws values of *X*~*m*~ for each municipality in a state and multiplies the value by the population of the municipality to sample a case count for the municipality. The sum of these is divided by the total state population to produce an expected state-resolution incidence for a year based on the municipality-resolution distribution for incidence. The 1,000 samples of *z* then produce an empirical distribution.

Relative proportions of incidence values in these simulated values were compared to the probabilities of each incidence value from the fitted state-resolution distribution through Kullback-Leibler (KL) divergence \[[@pone.0235920.ref041]\]. KL divergence represents the additional information needed when using one distribution to describe data from another distribution. By measuring dissimilarity, it has an inverse relationship to Mutual Information, which represents similarity of variables \[[@pone.0235920.ref041]\]. Thus, KL divergence is a measure of the Value of Information \[[@pone.0235920.ref042]\]. For two random variables, denoted A and B, the KL divergence from A to B, compared to the Shannon entropy in the distribution of A, shows a relative increase in information, using bits as units, needed to describe the distribution of B with that of A \[[@pone.0235920.ref041]\]. This is shown in the ratio of KL divergence to Shannon entropy (denoted *H)*, which can be defined as the Required Relative Information Gain (RRIG), where $$RRIG = \frac{KL_{A\rightarrow B}}{H_{A}}$$ shows the needed increase in information for the distribution of B to describe data from the distribution of A \[[@pone.0235920.ref041]\]. A value of 1 represents an information increase by 100%, or a doubling of information, though this is not an upper bound. A large RRIG value is indicative of distinct differences between distributions, indicating that characterizations of VL incidence are sensitive to the resolution of surveillance. An RRIG above 5% was selected a priori as a threshold for having a distinct difference in distribution.

### 2.3.2 Sensitivity to spatial scale {#sec007}

The aim of comparing spatial scales involves comparing the municipality-resolution distributions of each state and of the nation. In the presence of scale invariance, individual states would have the same or similar distributions, which would be similar to the distribution for the nation. Distributions for municipality-resolution case counts for the nation and each state were compared through RRIG.

All analyses were performed using R version 3.6.0 \[[@pone.0235920.ref043]\]. The 'poweRlaw' package was used to calculate probability density and mass for the Power Law distribution \[[@pone.0235920.ref044]\].

3. Results {#sec008}
==========

Of the 26 states in Brazil, 22 were included in analyses since they all observed more than five nonzero unique annual municipality-resolution incidence values over the study period ([S1 Table](#pone.0235920.s001){ref-type="supplementary-material"}). The remaining four states were excluded because their incidences over the 11 years did not provide enough unique values to reliably fit a distribution. All 18 endemic states from 2015 \[[@pone.0235920.ref035]\] were included as well as Espírito Santo, Paraná, Rondônia, and Roraima. [Fig 2(a) and 2(b)](#pone.0235920.g002){ref-type="fig"} shows total case counts by state and by municipality over the entire time period.

![Total case counts by (a) municipality and (b) state between 2004 and 2014.](pone.0235920.g002){#pone.0235920.g002}

3.1 Fitted distributions {#sec009}
------------------------

The uniform distribution for nationwide municipality-resolution incidence was not able to converge after increasing the iteration count to 200,000. All other distributions converged to optimal values. The best fitting municipality-resolution distributions for individual states varied. Annual incidence values from ten states were best fit by the rounded Gamma distribution, incidences from seven states were best fit by the Poisson distribution, incidences from three states were best fit by the Zero Inflated Poisson distribution, and incidences from two states were best fit by the Zero One Inflated Poisson distribution. Specific parameters are shown by state in [Table 2](#pone.0235920.t002){ref-type="table"}. Plots of the probability mass functions of each state's municipality-resolution distribution are shown in [Fig 3](#pone.0235920.g003){ref-type="fig"}. Nationwide, the best fitting distribution for municipality-resolution incidence was the Gamma distribution, and the best fitting distribution for state-resolution incidence was the Zero One Inflated Poisson distribution ([Table 2](#pone.0235920.t002){ref-type="table"}). No notable differences were seen in distributional fit among VL endemic and non-endemic states.

![Probability mass functions for distributions fit to municipality-resolution incidences among states and for the nation.\
Incidences were fit by either (a) a Poisson distribution, including distributions with zero and one inflations, or (b) a Gamma distribution.](pone.0235920.g003){#pone.0235920.g003}

10.1371/journal.pone.0235920.t002

###### Distributions for municipality-resolution incidences by state, municipality-resolution incidence nationwide, and state-resolution incidence nationwide.

KL/H calculated from [Eq (3)](#pone.0235920.e016){ref-type="disp-formula"} shows comparisons of fitted distributions to that for the nationwide municipality-resolution distribution (reference).

![](pone.0235920.t002){#pone.0235920.t002g}

  State                                     Distribution                Mean    Variance   KL/H
  ----------------------------------------- --------------------------- ------- ---------- -----------
  AL[\*](#t002fn001){ref-type="table-fn"}   Poisson(0.234)              0.234   0.234      0.456
  BA[\*](#t002fn001){ref-type="table-fn"}   Gamma(0.078, 0.022)         3.545   161.157    0.191
  CE[\*](#t002fn001){ref-type="table-fn"}   Gamma(0.191, 0.038)         5.026   132.272    0.824
  ES                                        Gamma(0.003, 0.002)         1.500   750.000    0.084
  GO[\*](#t002fn001){ref-type="table-fn"}   Gamma(0.016, 0.016)         1       62.5       0.009
  MA[\*](#t002fn001){ref-type="table-fn"}   ZOIP(0.599, 0.004, 7.292)   2.899   15.605     1.154
  MG[\*](#t002fn001){ref-type="table-fn"}   Gamma(0.024, 0.020)         1.2     60         0.001
  MS[\*](#t002fn001){ref-type="table-fn"}   Poisson(0.378)              0.378   0.378      0.791
  MT[\*](#t002fn001){ref-type="table-fn"}   Gamma(0.015, 0.003)         5       1666.667   0.007
  PA[\*](#t002fn001){ref-type="table-fn"}   Gamma(0.094, 0.022)         4.273   194.215    0.289
  PB[\*](#t002fn001){ref-type="table-fn"}   Poisson(0.077)              0.077   0.077      0.155
  PE[\*](#t002fn001){ref-type="table-fn"}   ZIP(0.819, 4.193)           0.759   3.365      0.263
  PI[\*](#t002fn001){ref-type="table-fn"}   ZIP(0.723, 14.44)           4.000   45.759     0.878
  PR                                        Poisson(0.003)              0.003   0.003      0.151
  RJ[\*](#t002fn001){ref-type="table-fn"}   Gamma(0.002, 0.009)         0.222   24.691     0.108
  RN[\*](#t002fn001){ref-type="table-fn"}   Poisson(0.085)              0.085   0.085      0.165
  RO                                        Poisson(0.013)              0.013   0.013      0.128
  RR                                        Gamma(0.015, 0)             15      15000      0.021
  RS[\*](#t002fn001){ref-type="table-fn"}   ZIP(0.998, 4.338)           0.009   0.046      0.146
  SE[\*](#t002fn001){ref-type="table-fn"}   ZOIP(0.776, 0.006, 5.254)   1.151   5.43       0.388
  SP[\*](#t002fn001){ref-type="table-fn"}   Gamma(0.014, 0.013)         1.077   82.840     0.01
  TO[\*](#t002fn001){ref-type="table-fn"}   Poisson(0.450)              0.450   0.450      0.960
  Brazil (Municipality)                     Gamma(0.024, 0.017)         1.411   83.045     Reference
  Brazil (State)                            ZOIP(0.379, 0.074, 2.82)    1.617   3.353      0.425

\* denotes states considered endemic for Visceral Leishmaniasis in 2015 \[[@pone.0235920.ref034], [@pone.0235920.ref035]\].

3.2 Comparisons across resolutions and scales {#sec010}
---------------------------------------------

The RRIG from [Eq (3)](#pone.0235920.e016){ref-type="disp-formula"} was used to quantify the similarities between distributions. The distributions fitted to state-resolution incidence and to the empirical distribution created from the national municipality-resolution distribution and [Eq (2)](#pone.0235920.e015){ref-type="disp-formula"} were first compared to determine the sensitivity to the resolution of surveillance data. The RRIG was 0.425, representing a needed increase of information by 42.5% ([Table 2](#pone.0235920.t002){ref-type="table"}). These results are indicative of strong sensitivity to the resolution of surveillance; the distribution for VL incidence by state does not accurately describe the distribution of incidence by municipality.

Comparisons between individual states' municipality-resolution incidence and national municipality-resolution incidence are shown in [Table 2](#pone.0235920.t002){ref-type="table"} using RRIG from [Eq (3)](#pone.0235920.e016){ref-type="disp-formula"}. The nationwide, municipality-resolution distribution is used as the reference for comparisons. The results show that six of the 22 states had incidence following a distribution close to that of the nation (RRIG\<0.05) ([Table 2](#pone.0235920.t002){ref-type="table"}, [Fig 4](#pone.0235920.g004){ref-type="fig"}). Any of these states could individually describe municipality-resolution incidence of the nation using their own incidence data. Because not all states adequately characterize national burden, true scale invariance was not seen, though self-similarity was seen in the selected states. The states that exhibited some self-similar behaviors all followed a Gamma distribution with generally similar parameters, particularly low values of shape parameters. Many of these states were located near the center of the nation ([Fig 4](#pone.0235920.g004){ref-type="fig"}).

![Expected values and families of fitted municipality-resolution distributions.\
States outlined in red had low KL divergence to Shannon entropy ratio with the national municipality-resolution distribution, indicating self-similarity.](pone.0235920.g004){#pone.0235920.g004}

4. Discussion {#sec011}
=============

This study aimed to assess the importance of the spatial scale and resolution used for VL surveillance and subsequent quantitative analyses. This is also reflective of the dynamics of VL at different scales determined by the distributions of incidence. Probability distributions were fit to incidences at different spatial resolutions and scales and then compared to determine if distributional fit was sensitive to the choice of scale and resolution. Aggregating municipality-resolution incidences into state-resolution incidences led to notably different probabilistic characteristics of disease burden, suggesting the existence of different processes driving disease occurrence at the two resolutions. When continuing surveillance at the municipality resolution, six states' incidences follow distributions that adequately describe those of each other as well as the nation of Brazil. While our results provide evidence against true invariance to resolution and scale, some self-similarity is seen in both distributional parameters and moments. This happens for states that are following a Gamma distribution, which implies medium-long range dispersal of cases and a potential tendency toward a power-law distribution for small scale and shape parameters.

The self-similarity seen in six states does not indicate that significant resources can be saved in Brazil by concentrating surveillance in a smaller area because they are not representative of the other states. The remaining states still need to undergo surveillance in order for their VL burden to be adequately characterized. Furthermore, it is of interest for public health to know where all VL cases occur in order to intervene in an outbreak. If greater self-similarity were seen, it would largely be of interest to researchers who could potentially generalize results of a smaller area to the nation of Brazil through conducting more intensive data collection for additional data in a smaller area. However, because scale invariance was not seen and self-similarity was seen in a small number of states, it is unlikely that descriptions of VL burden in a smaller region of Brazil are generalizable to the entire nation. These considerations consider the current observed state, for instance in case of a widespread propagation of the disease in long range.

Differences in municipality-resolution distributions among states suggest that different factors may influence VL risk across states. Environmental factors shown to influence VL case risk include vector populations, canine cases, precipitation \[[@pone.0235920.ref045]\], proximity to wooded areas \[[@pone.0235920.ref046]\], land use, deforestation \[[@pone.0235920.ref047]\], temperature, and humidity \[[@pone.0235920.ref048]\]. The question of resolution dependence is targeting whether the elementary unit at which we look into VL dynamics makes a difference for reproducing the distributional representation of VL incidence at the scale of analysis. These natural phenomena related to VL burden may differ across spatial scales and resolutions, similarly to other physical phenomena \[[@pone.0235920.ref049]\]. Though vector populations and precipitation do not explicitly conform to local political boundaries, different regions of Brazil likely see differences in these risk factors through differences in managing socio-ecological factors. These facts and the finding that distributions across states differ (also varying when resolution varies) are important considerations when analyzing disease data. It would be advisable to analyze data for individual locations \[[@pone.0235920.ref045], [@pone.0235920.ref048], [@pone.0235920.ref050]\] or use random effects \[[@pone.0235920.ref036]\].

The results from this study do not necessarily suggest that one spatial resolution is more "correct" than another or favor a particular resolution for analysis. The resolution for future statistical analyses should rely on the research question being posed and desired interpretation of results. However, the resolution dependence implies that, assuming accuracy and precision in assigning municipalities to observed cases, aggregating incidence to the state resolution likely introduces ecological fallacy. Thus, high resolution is likely beneficial to capture disease dynamics accurately. These results also illustrate the intuitive modifiable areal unit problem quantitatively by providing, through the distributional fits, a way to quantitatively observe the severity of the problem in the application of VL incidence. For high-resolution incidence, the most likely VL dynamics are represented by the Gamma distribution. These considerations should be always taken into account when collecting and analyzing data because they indicate that the choice of resolution will impact model results and their interpretation. Data characterizations and analyses at one resolution are not interchangeable for characterizations and analyses at the other resolution. A related point to note is that diligent surveillance is important when conducted at a finer spatial resolution to ensure accuracy of municipalities that are matched to cases.

This study is, to the authors' knowledge, the first to examine VL incidence for sensitivity to scale and resolution of surveillance data by finding best-fitting distributions to characterize incidence. Other studies have analyzed the fractality of other diseases, such as cholera, and how that is important for a simple estimation of disease spread in term of geography and magnitude \[[@pone.0235920.ref051]\]. Similar distribution fitting processes are used in veterinary epidemiology \[[@pone.0235920.ref052]\], but less frequently in human disease epidemiology. This analysis is important for informing future disease burden by providing location-specific estimates of expected annual incidence.

The findings of this study can benefit surveillance, healthcare infrastructure, digital epidemiology, and public health research focused on disease ecology. Care for an individual VL patient in Brazil, including diagnosis, treatment, and medical care, is estimated to be approximately \$500 (US) (plus an additional \$1470 (US) for secondary prophylaxis among VL patients with HIV) and lasts between seven and 20 days \[[@pone.0235920.ref053]\]. This is a high individual healthcare cost: yet, designing optimal surveillance that allows public health practitioners to understand and prevent VL is an incredibly valuable task socially and economically. These results and methods (applicable to any disease) can optimize disease data analysis and surveillance for the reduction of the systemic disease burden.

Using only VL incidence data and not introducing other data sources provides focus on what would be the outcome variable of a typical statistical analysis independently of any other predictors that may be introduced. Refitting models at multiple resolutions or scales assumes that the outcome, in this instance VL incidence, follows the same distribution in each scale and/or resolution. For example, using a lognormal regression model with two resolutions assumes that incidence at both resolutions follows a lognormal distribution, which may not be correct. When analyzing municipality-resolution cases, not all states have distributions in the same family, and distributions following the same family have different parameterizations because of the likely differential importance of the underlying socio-environmental drivers. The latter point further motivates the use of Bayesian hierarchical models or other models, for instance statistical physics and/or information theoretic models, which are able to handle the information of scale and resolution controlling factors.

We show that the information theoretic RRIG can determine the amount of information needed to describe the data using different resolutions or scales. It can be used as an information theoretic tool for scaling (downscaling or upscaling, depending on the purpose) epidemiological data considering their value and underlying distributions.

An additional point of novelty is the use of the ZOIP and Gamma distributions to characterize VL incidence. Both distributions are uncommonly used for infectious disease incidence, despite closely fitting observed data. The ZOIP distribution offers the advantage of specifically fitting high frequencies of counts of one, describing single spurious cases. The Gamma distribution is advantageous for placing high probability on low values. More specifically into the statistical physics of disease ecology, the Gamma distribution has similarities to heavy tail distributions (for small shape and scale parameters) and ZOIP represents Poisson distributions highlighting local/random and medium-range disease dynamics. The higher statistical complexity (e.g. related to the number of parameters) of ZOIP reflects the random Poissonian nature of the disease with other factors, while the lower complexity of the Gamma reflects its more simple nature.

These analyses do not consider dependence on temporal resolution and scale although time and space for stochastic processes relate to each other. The data in this study include yearly case counts; having smaller time units such as months would allow for such consideration Additionally, distributions are assumed to remain constant over the 11 years of observation considering the very minor variations in the inferred distributions that lead to consider VL dynamics at stationary state. Increases have been seen in VL cases over time \[[@pone.0235920.ref054]\], though case counts between 2000 and 2014 have remained more consistent compared to previous decades \[[@pone.0235920.ref055], [@pone.0235920.ref056]\], indicating that these results are not likely to be sensitive to this assumption. Populations over this time period by municipality generally showed small changes. The mean change in population by municipality was an increase of approximately 11% between 2004 and 2014, and the middle 90% of changes were between a 12% decrease and a 41% increase \[[@pone.0235920.ref037]\]. These considerations motivate extensions of this study to define the relationship between space and time for scale dependent processes.

Another assumption made in this study is the ability to fit a single probability distribution for VL incidence for the entire nation of Brazil. Since not all of the included states are considered endemic for VL \[[@pone.0235920.ref035]\], fitting a single distribution for incidence nationwide assumes that the same distribution can represent incidence in both endemic and non-endemic states. However, if conducing a study using VL incidence data, this should be considered in the quantitative analyses that would follow from the results of this study. Other heterogeneities across the nation, such as affluence, urbanization, or climate, which may impact VL incidence, similarly are not considered for distribution fitting but should be accounted for during subsequent analyses.

The results of this study rely on the data collected. VL case data were collected through passive surveillance and notification to the Ministries of Health. It is commonly known that reported cases of infectious diseases only represent a portion of the total cases \[[@pone.0235920.ref057]--[@pone.0235920.ref059]\], commonly representing the most severe cases. This limits the accuracy of the data, and therefore distribution fitting, by the ability to report cases as well as the potential heterogeneous severity of VL cases. It is also likely that across locations in Brazil, amounts of underreporting of cases differ. The results of this study rely on the assumption that reported cases provide an adequate representation of disease burden. Furthermore, inclusion of both endemic and non-endemic states in the analyses may lead to the inclusion of case data representing both typical VL incidence as well as atypical VL incidence. This could potentially affect distribution fitting if underlying processes leading to typical and atypical incidence differ.

A limitation of this study is the reliance on the criterion for determining differences when comparing distributions and algorithm used for determining best fitting distribution families and parameters. There are numerous methods for performing both tasks, and different methods may lead to slightly different conclusions. The methods of this study do, however, use assumption-free criteria in order to generate the results. A sensitivity analysis was conducted to determine if the number of samples drawn to generate the empirical state-resolution distribution described in section 2.2.1 using [Eq (2)](#pone.0235920.e015){ref-type="disp-formula"} might impact RRIG values, and it was found that using 1,000; 2,000; 5,000; and 10,000 samples did not yield distinct difference in RRIG values and no differences in interpretations and conclusions. The threshold choice of 0.05 for the RRIG was an a priori decision. Since this is a continuous value, it used in decision-making in other contexts, other choices for thresholds would be valid.

Another important note is that this study used surveillance units of different sizes, examining aggregation of municipalities of differing land areas and populations and comparisons among states with different areas and populations. This results from using administrative districts, and still remains useful by using the units recorded in infectious disease surveillance. However, diseases know no political boundaries; yet, an ecosystem-based discretization to define homogeneous high resolution units would be preferable for surveillance such as one based on Digital Elevation Models from which to derive physical ecosystem boundaries that are relevant to disease spread. This would also help the control of diseases to assign to different political entities.

A related topic of research is the existence of spatial autocorrelation in the data. Values of Moran's I using municipality-resolution incidence nationwide showed strong evidence of spatial clustering. Evidence of spatial autocorrelation aligns with the finding that distributional fits for VL incidence are not interchangeable across resolutions and scales. Having cases concentrated in particular local regions would suggest that local factors are important to VL dynamics and should be accounted for in future research. This implies that disease dynamics are local as already highlighted by differing fitted distributions across states, which is consistent with previous works \[[@pone.0235920.ref060], [@pone.0235920.ref061]\]. Any future analyses on VL in Brazil would benefit from the use of methods that account for spatial autocorrelation. For the purposes of distribution fitting, finding distributional families that most accurately characterize incidence is of greater importance than determining a covariance structure that most accurately reflects autocorrelation. Determining clusters and covariance structures is an important component of analysis that follows the results of this study.

5. Conclusions {#sec012}
==============

The choice of spatial resolution and scale in infectious disease research is shown to have a potential impact on future results and conclusions when using statistical and mathematical models. The findings from this study should be considered prior to designing quantitative analyses. Finding sensitivity to the spatial resolution and spatial scale of VL surveillance data is of interest to both researchers and government officials for preparedness. Analyses using VL data should consider the findings of this study when planning analyses and controls related to disease processes or population incidence trajectories. Surveillance agencies should note that accurate surveillance by municipality is important because measuring incidence by state alone does not offer an equivalent characterization, and while there do exist small areas with incidences that can describes those of the others, nationwide surveillance at high resolution remains important to consider likely heterogeneity of processes contributing to VL burden. This applies to other diseases with incidences that depend on the scale and resolution of surveillance, which should be examined to assure whether this dependence does exist.

Supporting information {#sec013}
======================

###### Frequency of incidence values by municipality within each state and by state for the nation.

(CSV)
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Click here for additional data file.

###### Best fitting parameterizations for each considered distribution and associated sum of absolute error (SAE) values.
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###### Original data with annual Visceral Leishmaniasis incidence by municipality in Brazil, 2004--2014 with R code used for analysis.

(ZIP)

###### 

Click here for additional data file.
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In infectious disease modelling, fitting disease data to a known statistical distribution is a common first step of the analyses, but oftentimes it is overlooked. The first great contribution of this work to VL modellers is summarised in table 2 -- the fitted distributions for country and state-level surveillance datasets. I do not recall seeing the gamma distribution in other VL studies, which usually apply the Poisson distribution. This has the potential to become an important reference for VL modelling exercises in Brazil.
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L289: "different processes driving disease occurrence" -- this made me think about the differences between disease occurrence and disease notification, which is the actual data that was analysed. Your discussion might also include comments on how underreporting of VL affect these analyses. It is very likely that underreporting varies among Brazilian states.

Fig. 1: In the map of Brazilian States there are some extra lines appearing where they should not, more specifically inside the states MS, GO, SP, ES and PE. This is probably an artefact of the shapefile that was used, it should be corrected.

Reviewer \#2: I thank the authors for this work on an interesting subject. I suggest minor revision according to these comments:
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The reviewer comments are seen in quotes, and responses to specific comments are found directly below relevant comments, with each paragraph beginning with the lead author\'s initials, JLS.

\"Reviewer \#1: This is a very relevant study that addresses the effect of spatial scales on visceral leishmaniasis surveillance data from Brazil. The manuscript is very well written and understandable. The methods are adequately explained, although some minor details can be added to improve reproducibility.

In infectious disease modelling, fitting disease data to a known statistical distribution is a common first step of the analyses, but oftentimes it is overlooked. The first great contribution of this work to VL modellers is summarised in table 2 -- the fitted distributions for country and state-level surveillance datasets. I do not recall seeing the gamma distribution in other VL studies, which usually apply the Poisson distribution. This has the potential to become an important reference for VL modelling exercises in Brazil.

The second main contribution is the effect of spatial scale and the importance of choosing the right dataset for your research question. This has been explored before in theory, but to the best of my knowledge this is the first time I see these scale comparisons in VL data from Brazil.

I recommend the acceptance of the manuscript after some minor details are clarified, specifically:

L125: Explain why the Federal District was not included in the dataset.\"

JLS: This study largely aimed to compare distributional fits at spatial resolutions, using incidence by municipality and by state. Because the Federal District is not a state with multiple municipalities, Visceral Leishmaniasis incidence cannot be aggregated to allow municipality-resolution and state-resolution incidence to be calculated. This clarification has been added to the text on line 133 of the revised manuscript.

\"L131: Give further info on exclusion criteria for municipalities. Were they excluded due to missing population data only or disease data as well?\"

JLS: Excluded municipalities were not present in the IBGE population data. This sentence was rewritten to make this clearer, and appears on line 140 of the revised manuscript.

\"L222: It would be very relevant, for reproducibility, if the R code used in the analyses were uploaded as supporting information or uploaded to a code repository such as GitHub.\"

JLS: The third supplemental material, originally containing the original data, has been replaced with S3_File.zip. This contains a folder with the original incidence data as well as the R code used for these analyses.

\"L289: "different processes driving disease occurrence" -- this made me think about the differences between disease occurrence and disease notification, which is the actual data that was analysed. Your discussion might also include comments on how underreporting of VL affect these analyses. It is very likely that underreporting varies among Brazilian states.\"

JLS: This is a very important note. This fact is very present in infectious disease literature. A paragraph has been added to the discussion highlighting that this study uses reported cases, which represent a subset of the true number of cases. This paragraph begins on line 418 of the revised document.

\"Fig. 1: In the map of Brazilian States there are some extra lines appearing where they should not, more specifically inside the states MS, GO, SP, ES and PE. This is probably an artefact of the shapefile that was used, it should be corrected.\"

JLS: We appreciate catching this detail. This has been fixed.

\"Reviewer \#2: I thank the authors for this work on an interesting subject. I suggest minor revision according to these comments:

Introduction section:

1\. "Urban area" Lines 98 and 101: Please check !\"

JLS: The citations associated with the statements indicate that Visceral Leishmaniasis has a canine reservoir in Brazil and that the disease has been seen in urban settings and is associated with urbanization in recent decades, in contrast to having been seen in rural settings previously. The wording has changed to reflect that canine reservoirs are not exclusively in urban settings and that the recent shift to greater incidence in urban settings occurred since 1980 rather than the most recent years.

\"2. Authors don\'t precise Leishmania species caused VL in Brazil.\"

JLS: Cases of VL in Brazil have been attributed to L. infantum. This has been added on line 90 of the revised manuscript.

\"MM section:

1\. Data collection: Please add subtitle for the first paragraph\"

JLS: This has been added.

\"2. 22 Brazilian states were included; please add data about epidemiological status: endemic/non endemic state!\"

JLS: Classifications of states as endemic/non endemic according to the Brazilian Ministries of Health, with citations, have been added, starting on line 104 of the revised manuscript as well as in Table 2.

\"Discussion section:

Authors must discuss according to other parameters: epidemiological status of the study area, type of infection\....\"

JLS: This point of epidemiological status has been included. Similarly, other heterogeneities across Brazil are not accounted for in the distribution fitting process, but should be considered in any modeling studies that follow. This has been added in the paragraph starting on line 409 of the revised manuscript as well as on lines 424-428.

JLS: The point of the type of infection connects with the other reviewer's comment regarding underreporting of cases, as the most severe cases are less commonly underreported. The severity of infection has been added as a point describing underreporting on lines 446-448 of the revised manuscript.
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: All comments have been addressed

Reviewer \#3: All comments have been addressed

Reviewer \#4: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Yes

Reviewer \#3: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: Yes

Reviewer \#3: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#2: Yes

Reviewer \#3: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#2: Yes

Reviewer \#3: Yes

Reviewer \#4: Yes
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6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: The authors have adequately addressed my comments. This version of the manuscript is now acceptable for publication.

Reviewer \#3: This study is a good study and it is recommended to be accepted for publish. some comments:

It is better to work on the resolution of the maps.

Specify the north and south directions on the map.

In the introduction, the mortality rate of visceral leishmaniasis in the world and Brazil should be mentioned.

Reviewer \#4: I would like to thank the authors for this interesting work on VL. Please find my detailed comments below:

The Modifiable Areal Unit Problem (MAUP) is a common problem for analyzing spatial data, which I think the authors have partially engaged by mentioning about the scale invariance problem. However, it is still unclear from the introduction as to where the research gap lies, when it is a common knowledge that changing the scale is highly likely to change the results or findings of a spatial analysis. The objective of the work was outlined well but the motivation of the work requires more clarity.

Line 145 to 146: Any reason why this decision was taken?

Line 152: What exploratory analyses were conducted and what criteria for suitability were set for choosing the distributions in Table 1? I see ZIP and ZOIP are used, which is understandable given the count nature of the data. But it is unclear as to why the exponential, gamma etc. models were necessary. This part of the manuscript could be a little tricky to deal with, as the justifications of the selection of the distributions need to be provided without making the methods too technical for the readers to understand. Again, the justification needs to be clear enough so that any readers with a geostatistical background can understand the rationale behind the selection and can benefit from this work.

Line 165: How was "()" or "the probability of observing an incidence o f cases per 100,000 person-years" determined? Did the process involve the computation of any expected number of cases? If yes, what method was applied for the computation?

Line 187: The authors have repeatedly mentioned this (or similar) term "inferential conclusions". I think it is better to clearly outline what this term entails for the readers to understand the methods better.

The left hand side of Eq2 is absent

Line 223: Any justification for this 5% threshold? Please include in the text for strengthening your selection.

Results have been presented well but the discussion needs to engage with the issue of spatial heterogeneity that has not been incorporated into the analysis. For example, Fig 1 shows the distribution of VL cases can possibly exhibit spatial clustering and even spatial autocorrelation. Under these circumstances, there is a good possibility that the incidence rates might not match across different scales, as the disease burden is not distributed equally across all the municipalities.
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7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: Yes: Samia BOUSSAA

Reviewer \#3: Yes: Eslam Moradi-Asl

Reviewer \#4: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Reviewer \#2: The authors have adequately addressed my comments. This version of the manuscript is now acceptable for publication.

JLS: We appreciate the reviewer's attention to our revision.

Reviewer \#3: This study is a good study and it is recommended to be accepted for publish. some comments:

It is better to work on the resolution of the maps.

JLS: All figures have an improved resolution.

Specify the north and south directions on the map.

JLS: The maps in Figures 2 and 4 contain a compass arrow pointing to North in the lower left corner of each map. Figure 1 does not contain this because it is a conceptual diagram; specific details of the orientation of Brazil are not crucial to its interpretation.

In the introduction, the mortality rate of visceral leishmaniasis in the world and Brazil should be mentioned.

JLS: This has been added. The global mortality rate, represented via estimates of total estimated cases and deaths, is reported on lines 102 and 103 of the revised manuscript. The estimated mortality rate in Brazil is reported on lines 107-110.

Reviewer \#4: I would like to thank the authors for this interesting work on VL. Please find my detailed comments below:

The Modifiable Areal Unit Problem (MAUP) is a common problem for analyzing spatial data, which I think the authors have partially engaged by mentioning about the scale invariance problem. However, it is still unclear from the introduction as to where the research gap lies, when it is a common knowledge that changing the scale is highly likely to change the results or findings of a spatial analysis. The objective of the work was outlined well but the motivation of the work requires more clarity.

JLS: This study's relevance to the MAUP is related to that to ecological fallacy. Few studies have quantified this, as this concept is intuitive. This study offers an example of a real quantification of this issue. These points are included in the introduction on lines 63-66 and in the discussion on lines 366-368 of the revised manuscript.

JLS: The second motivation and objective of this study was to examine scale invariance, which differs in that the size of the entire area considered is examined, while keeping the areal units constant. This is motivated by the ability to use a subset of the nation of Brazil to describe the nation's VL burden, as described in the introduction.

Line 145 to 146: Any reason why this decision was taken?

JLS: Previous studies exploring this have done so by first posing a substantive research question and then following up by repeating analyses. The argument made in this manuscript is that, while providing some insight, the repeated analysis is subject to the assumptions of the model. Because this study aimed to address the question of scale/resolution sensitivity as the primary objective, a model using other covariates was not wanted. Fitting the distributional fit represents the simplest way of describing disease incidence and would directly relate to either a stochastic node of a mathematical model or a link function of a statistical model. An additional sentence emphasized this point on lines 163-166 of the revised manuscript.

Line 152: What exploratory analyses were conducted and what criteria for suitability were set for choosing the distributions in Table 1? I see ZIP and ZOIP are used, which is understandable given the count nature of the data. But it is unclear as to why the exponential, gamma etc. models were necessary. This part of the manuscript could be a little tricky to deal with, as the justifications of the selection of the distributions need to be provided without making the methods too technical for the readers to understand. Again, the justification needs to be clear enough so that any readers with a geostatistical background can understand the rationale behind the selection and can benefit from this work.

JLS: The exploratory analyses were primarily visualizations and examining summary statistics such as quantiles and moments. Suitability refers to a distribution having a nonnegative support. The purpose of selecting a variety of distributions was to consider many common distributional families to explore the possibility of one providing the closest fit to the data. These points were made more explicit in the text and appear on lines 172-173 of the revised manuscript.

Line 165: How was "()" or "the probability of observing an incidence o f cases per 100,000 person-years" determined? Did the process involve the computation of any expected number of cases? If yes, what method was applied for the computation?

JLS: The values of p(x) were calculated using the formulas in Table 1. These were evaluated through base R functions such as rpois(), runif(), etc, based on the distributional family being evaluated. In the cases of the Power Law distribution, the 'poweRlaw' package was used as cited at the end of the methods section.

Line 187: The authors have repeatedly mentioned this (or similar) term "inferential conclusions". I think it is better to clearly outline what this term entails for the readers to understand the methods better.

JLS: We appreciate this point. The intended message is that the finding that the scale and resolution choices can change the distributional fit of incidence implies that any statistical or mathematical models using this data could suffer from similar sensitivity given choices of scale and resolution. The wording has been changed throughout the manuscript to explicitly state this every time with consistent wording. Notable changes include those on lines 210-213 and 437-438 of the revised manuscript.

The left hand side of Eq2 is absent

JLS: A value has been added for the left hand side. It is also referenced in a sentence added to the end of the paragraph (line 232) to clarify the methods used.

Line 223: Any justification for this 5% threshold? Please include in the text for strengthening your selection.

JLS: The 5% threshold was decided a priori, and not based on previous use. This has been added on line 251 of the revised manuscript and a sentence has been added to the discussion on lines 452-464 that states this explicitly.

Results have been presented well but the discussion needs to engage with the issue of spatial heterogeneity that has not been incorporated into the analysis. For example, Fig 1 shows the distribution of VL cases can possibly exhibit spatial clustering and even spatial autocorrelation. Under these circumstances, there is a good possibility that the incidence rates might not match across different scales, as the disease burden is not distributed equally across all the municipalities.

JLS: The discussion of spatial heterogeneity has been expanded to incorporate these points more directly. This was noted in the last paragraph of the discussion section. It has been made into its own paragraph with an addition to make this point more explicit.

JLS: In addition to these specific comments, the manuscript has been checked for any spelling/grammatical errors as well as citations and other formatting matters.
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